Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Chemical Engineering at the University of Southampton. The project will provide advanced training in synthetic organic chemistry and structural characterisation, with opportunities to interact with
-
Chemical Engineering at the University of Southampton. The project will provide advanced training in synthetic organic chemistry and structural characterisation, with opportunities to interact with
-
in the School of Chemistry and Chemical Engineering at the University of Southampton. The project will provide advanced training in synthetic organic chemistry and structural characterisation, with
-
National University of Singapore (NUS) invites applications for a Research Fellow position in Advanced Membrane Science and Engineering for Sustainable Environmental Applications. The successful
-
experience in integrated evidence generation plan (IEGP) development, RWE generation, HEOR strategy and analytics, health technology assessment, value dossier development, and payer engagement. Year 2 consists
-
students and 1,900 employees. ... (Video unable to load from YouTube. Accept cookie and refresh page to watch video, or click here to open video) About the position The Faculty of Technology, Natural
-
. About GSK GSK is a focused biopharma company with strong momentum and big ambitions, to unite science, technology, and talent to get ahead of disease together. We aim to positively impact the health
-
Fellowship based in Cambridge, Massachusetts. About Sarepta Therapeutics Sarepta is a global biotechnology company on an urgent mission to engineer precision genetic medicine for rare diseases that devastate
-
of Agder (UiA), Faculty of Engineering and Science as a PhD Research Fellow in Terrestrial Ecology, affiliated to the Department of Natural Sciences , for a period of three years. The position is located
-
. Guided by this full-spectrum approach, we are committed to making CRISPR-based medicines a reality for people living with genetic diseases and to creating novel engineered cell therapies for various